Keyphrases
Multi-stakeholder
100%
Delphi Consensus
100%
Netherton Syndrome
100%
Core Outcome Set
100%
E-Delphi
100%
Clinical Research
28%
Clinical Care
28%
Clinical Practice Guidelines
28%
Effectiveness Study
28%
Core Outcome Measures
28%
Allergy
14%
Effective Treatment
14%
Discussion Groups
14%
Family Members
14%
Treatment Outcome
14%
Best Medical Treatment
14%
Treatment Options
14%
Multidisciplinary Approach
14%
Literature Search
14%
Incomplete Knowledge
14%
Epidermis
14%
Treatment Comparison
14%
Physical Development
14%
Treatment Side Effects
14%
Guideline Development
14%
Search Methods
14%
Pathogenic Variants
14%
Development Outcomes
14%
Classification Basis
14%
Nutrition Outcomes
14%
Emotional Functioning
14%
Consensus Conference
14%
Serine Protease Inhibitor
14%
Infection Outcome
14%
Outcome Instrument
14%
Assessment Results
14%
Treatment Results
14%
Likert Scale
14%
Measurement Instrument
14%
Keratinization
14%
Literature Classification
14%
International Classification of Functioning
14%
Uniform Reporting
14%
Skin Barrier
14%
Kazal Type
14%
Barrier Impairment
14%
Family Representatives
14%
Netherton
14%
Biochemistry, Genetics and Molecular Biology
Maturation
100%
Sensation
100%
Serine Protease Inhibitor
100%
Physical Development
100%
Keratinization
100%
Food Science
Serine
100%
Nutrition
100%
Sensation
100%
Medicine and Dentistry
Netherton Syndrome
100%
Diseases
28%
Side Effect
14%
Infection
14%
Sensation
14%
Likert Scale
14%
Physical Development
14%
Keratinization
14%
Maturation
14%
Serine Peptidase Inhibitor Kazal Type 5
14%
Nutrition
14%
Neuroscience
Serine Protease Inhibitor
100%
Likert Scale
100%
Pharmacology, Toxicology and Pharmaceutical Science
Netherton Disease
100%
Diseases
28%
Infection
14%
Side Effect
14%
Serine Peptidase Inhibitor Kazal Type 5
14%